Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Assets (2016 - 2025)

Nutex Health's Current Assets history spans 16 years, with the latest figure at $401.5 million for Q1 2025.

  • For Q1 2025, Current Assets rose 300.08% year-over-year to $401.5 million; the TTM value through Mar 2025 reached $401.5 million, up 300.08%, while the annual FY2024 figure was $292.5 million, 221.94% up from the prior year.
  • Current Assets for Q1 2025 was $401.5 million at Nutex Health, up from $292.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $401.5 million in Q1 2025 and bottomed at $4.0 million in Q1 2022.
  • The 5-year median for Current Assets is $100.4 million (2024), against an average of $123.1 million.
  • The largest annual shift saw Current Assets skyrocketed 97963.86% in 2021 before it crashed 40.34% in 2022.
  • A 5-year view of Current Assets shows it stood at $154.0 million in 2021, then plummeted by 36.39% to $98.0 million in 2022, then decreased by 7.27% to $90.8 million in 2023, then surged by 221.94% to $292.5 million in 2024, then skyrocketed by 37.28% to $401.5 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Current Assets are $401.5 million (Q1 2025), $292.5 million (Q4 2024), and $119.8 million (Q3 2024).